iShares Biotechnology ETF

NASDAQ: IBB
$128.02
+$1.91 (+1.5%)
Closing price April 23, 2024
The iShares Biotechnology ETF, managed by BlackRock Fund Advisors, is a fund that focuses on the biotechnology sector within the United States. It aims to mirror the performance of the NYSE Biotechnology Index by investing in a mix of growth and value biotech stocks across various market sizes. Launched in 2001 and based in the U.S., this ETF uses a representative sampling strategy to select its investments, offering investors exposure to the biotech industry.

Short Interest in Biotech Wanes (ALXN, AMGN, ARNA, BIIB, CELG, DNDN, GILD, ILMN, ONXX, PCYC, REGN, VRTX, VVUS, IBB)
The short interest in biotech stocks is generally falling, judging by the short interest changes from August 31 settlement date versus the August 15 settlement date. We have tracked the key short...
Trey Thoelcke
Published:

NASDAQ Changes Up Biotech Index Members & Weightings
Index changes are generally speaking a fairly routine event.  They can also create underlying moves in the companies added and deleted from them as money management firms often buy and sell shares,...
Jon C. Ogg
Published:
Last Updated:

High-Premium Biotech M&A Continues (AMGN, CELG, MITI, IBB)
Thursday brought yet more merger and acquisition news in the ongoing buyout trends in the biotech sector.  Amgen Inc. (NASDAQ: AMGN) announced that it is going to acquire Micromet, Inc. (NASDAQ:...
Jon C. Ogg
Published:
Last Updated:

Top Biotech Stock Picks For 2012 (ARIA, DNDN, GILD, HGSI, ILMN, INCY, JAZZ, LIFE, THRX, IBB, XBI)
The biotech sector has seen its share of ups and downs in 2011 and prior years.  It is almost always the case that some of the top performing stocks each year come from this sector due to the...
Jon C. Ogg
Published:
Last Updated:

Measuring Pre-Earnings Upside in Biotechs (DNDN, HGSI, GILD, AMLN, ARIA, INCY, IBB, XBI, BBH)
We have compiled a detailed list of expected upside in the biotech sector.  The sector has consolidated and now there is about to be a rush of earnings reports from tomorrow’s emerging drug...
Jon C. Ogg
Published:
Last Updated:

ETF Watch: Biotechs Fighting M&A Shrinkage (BBH, AMGN, GILD, BIIB, XBI, FBT, CRA, CEPH, IBB)
Biotech is becoming the ever-shrinking stock sector.  It is almost weekly now that a new biotech acquisition is announced.  Big Pharma in the United States and large drugmakers internationally...
Jon C. Ogg
Published:
Last Updated:

IPO Watch: The Alternative Genzyme IPO (SNY, GENZ, GCVRZ, BBH, IBB, FBT)
The proposed buyout of Genzyme Corporation (NASDAQ: GENZ) by Sanofi-Aventis (NYSE: SNY) should close this week.  We are about to get a new Genzyme security on the market and that will be the...
Jon C. Ogg
Published:
Last Updated:

Top Investment Trends For Futurists (FFD, AFK, EZA, PHO, PIO, PXN, TINY, LIT, BP, PBW, PZD, PBD, REMX, NLR, MOO, GLD, BBH, IBB, FPX, IPOSX)
Futurists are an odd lot.  Generally, they are authors, scientists,  consultants and economists.  What many people don’t know is that investors follow this philosophy as well.  Their goal is to...
Douglas A. McIntyre
Published:
Last Updated:

BioHealth Business Daily (AGEN, ARRY, GENZ, GILD, HGSI, NPSP, QLTI, RPTP, STEM, BBH, IBB, PBE)
Today’s version of the BioHealth Business Daily is rather different as we have a big disappointment from one of the top biotech operations in the world.  BioHealth stocks moving on news and after...
Jon C. Ogg
Published:
Last Updated: